Brought to you by 
Series B results in $12.7mm for Cayenne Medical
29 Sep 2020
Executive Summary
Cayenne Medical (minimally invasive procedures for ACL reconstruction) raised $12.7mm in a Series B financing of preferred shares. Split Rock Partners led the round and was joined by MB Ventures and private individuals.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B results in $12.7mm for Cayenne Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice